Endocrinology News

A parathyroid hormone prodrug developed to treat hypoparathyroidism received FDA approval, according to an industry press release.

As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.

Transgender youths discussed social concerns, facing hostility and being worried about losing access to care when interviewed about legislation prohibiting gender-affirming care, according to findings published in LGBT Health.

Maternal obesity may be linked to increased risk for sudden unexpected infant death, results from aa cohort study in JAMA Pediatrics suggest.

Adults with obesity and type 2 diabetes had reductions in body weight and HbA1c 1 year after undergoing an endoscopic procedure that resurfaces the duodenum lining, according to top-line results from a real-world registry study.

Young people with type 1 diabetes enrolled in a digital health program with early initiation of continuous glucose monitoring plus remote patient monitoring had better glycemic outcomes than historical controls, according to study data.

On June 28, the U.S. Supreme Court ruled 6-3 in Loper Bright Enterprises v. Raimondo, Secretary of Commerce to overturn a decades-old decision known as the “Chevron deference.”

FDA approved Medtronic’s next-generation continuous glucose monitor for people with diabetes, according to an industry press release.

Algorithms for initiating insulin among noncritically ill adults varied widely across 20 U.S. academic hospitals, according to a brief report published in Diabetes Technology & Therapeutics.

Worse physical function may be the factor contributing to an increased fracture risk for women aged 75 to 80 years with type 2 diabetes, according to a study published in JAMA Network Open.